Articles By Jack Cush, MD
FDA Biosimilar Approval of Inflectra Viewed as a Milestone Advance
On February 9th, the Food and Drug Administration (FDA) Arthritis Advisory Committee voted 21-3 in favor of approving the infliximab biosimilar, CT-P13/Inflectra, for use in all of infliximab's indications.
Read Article
Cardiology Anti-inflammatory Trial Fails to Improve CV Outcomes
Researchers at Brigham and Women's Hospital, Boston evaluated the efficacy and safety of the anti-inflammatory drug losmapimod on cardiovascular outcomes given to patients with a history of myocardial infarction and CV risk factors.
Read Article
ACC Publishes Guidelines for Non-Statin Therapies
The American College of Cardiology has released its expert consensus guidance regarding the use of non-statin therapies to lower cholesterol in high-risk patients.
Read Article
Severe Psoriasis Associated with a Renal Disease Risk
There have been several reports of psoriasis being linked to chronic renal disease in the literature. Another population-based study has also found a link between severe psoriasis and kidney disease.
Read Article
Treating OA Knee Effusions with Low-Dose Spironolactone
Knee effusions in osteoarthritis are estimated to occur in 44% of patients, and more than half of these are painful. Management of knee OA with effusions can be problematic given the treatment options and the high recurrence rate.
Read Article
Opioid Use in Rheumatoid Arthritis
Opioid use and abuse is at an all time high. Epidemiologic and public health analyses have led to greater stringency and attempts to limit use have adversely effected those with arthritis.
Read Article
Incidence of Psoriatic Arthritis Among Psoriasis Patients
Researchers at the University of Toronto have prospectively studied a cohort of 464 psoriasis patients without a diagnosis of arthritis and followed them over 8 years to estimate the incidence and frequency of psoriatic arthritis (PsA).
Read Article
Antibiotics Fail to Treat Chronic Symptoms of Lyme Disease
(Reuters Health) - Twelve weeks of antibiotic therapy proved ineffective at combating the long-term symptoms seen in some people who have had Lyme disease, a new test of 280 sufferers found. (Citation source http://buff.ly/1Rs21R5)
Read Article
Drug Safety Bulletin - March 2016
RheumNow is committed to reporting safety issues in our monthly Drug Safety Bulletins, wherein we will update you with reports of new, ongoing and resolved Drug Shortages that will affect rheumatology. If you have suggestions or information about specific drug sho
Read Article
